Ischaemic Heart Disease Clinical Trial
— SheppHeartOfficial title:
SheppHeartCABG Shaping Outcomes by Exercise Training and Psycho-education in Phase 1 for Coronary Artery Bypass Grafting Patients
Verified date | November 2015 |
Source | Rigshospitalet, Denmark |
Contact | n/a |
Is FDA regulated | No |
Health authority | Denmark: Danish Dataprotection Agency |
Study type | Interventional |
Patients undergoing coronary artery bypass graft surgery often experience a range of
problems and symptoms related to the procedure and the underlying heart disease. These
problems include anxiety and depressive symptoms, immobility issues, complications such as
wound seeping, neck and shoulder pains, interrupted and insufficient sleep. Over the last 2
decades, cardiac rehabilitation has become recognized as a significant component in the
continuum of care for persons with cardiovascular disease. Furthermore, cardiac
rehabilitation has undergone a significant evolution moving from a focused exercise
intervention to a comprehensive disease management program. In Guidelines for Coronary
Artery Bypass Graft Surgery cardiac rehabilitation is described to include early ambulation
during hospitalisation, and outpatient prescriptive exercise training beginning 6-8 weeks
following surgery. Our hypothesis is that physical exercise with moderate intensity and a
psycho-educative component as a part of cardiac rehabilitation can begin in early
postoperatively during hospitalising. Results from studies on phase 1 rehabilitation in
coronary artery bypass graft surgery patients are promising. However, no randomised trials
have been conducted, and evidence is therefore lacking.
The objective of this pilot trial is to investigate the effect of a phase 1 comprehensive
cardiac rehabilitation programme consisting of a psycho-educative component, an
exercise-training component including pulmonary training, cycling, neck and shoulder
exercises, these in combination plus treatment as usual and treatment as usual in patients
who undergo coronary artery bypass grafting.
SheppHeartCABG is an investigator-initiated 2 x 2 factorial randomised clinical pilot trial
with blinded outcome assessment. Recruitment from one site with 1:1:1:1 central
randomisation to phase 1 rehabilitation; 1) exercise-training plus usual care, 2)
psycho-educative plus usual care 3) exercise-training and psycho-educative plus usual, 4)
usual care alone.
Status | Completed |
Enrollment | 60 |
Est. completion date | April 2014 |
Est. primary completion date | November 2013 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - 18 years or older. - Persons with ischaemic heart disease referred to elective coronary artery bypass graft surgery. - Speaks and understands Danish. - Provide written informed consent. Exclusion Criteria: - Patients at intermediate or high risk according to their cardiovascular status - Patients with illness limiting the ability to exercise. - Patients without permanent residence. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in peak oxygen uptake (VO2) between groups | At hospital discharge and 4 weeks following surgery | Yes | |
Primary | Change in self-reported health measured by SF-36 between groups | At hospital discharge and 4 weeks following surgery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Active, not recruiting |
NCT03603210 -
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
|
||
Completed |
NCT00151658 -
Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)
|
N/A | |
Recruiting |
NCT04193475 -
Machine Learning in Quantitative Stress Echocardiography
|
||
Completed |
NCT02290262 -
SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting
|
N/A | |
Active, not recruiting |
NCT03736018 -
Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients
|
N/A | |
Completed |
NCT02849067 -
Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session
|
N/A | |
Recruiting |
NCT05045118 -
The Impact of Structured Patient Education Material (SPEM) in Improving Clinical and Behavioural Outcomes in Home-based Cardiac Rehabilitation Program Participants: A Pilot Study
|
N/A | |
Completed |
NCT04901767 -
Coronary Artery Endothelial Dysfunction With Drug Coated Balloons
|
||
Enrolling by invitation |
NCT03674255 -
Echocardiography: Value and Accuracy at REst and STress
|
||
Active, not recruiting |
NCT03171311 -
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
|
N/A | |
Recruiting |
NCT04768283 -
Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome
|
N/A | |
Completed |
NCT02315001 -
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
|
Phase 2 | |
Completed |
NCT01796353 -
Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients
|
N/A | |
Recruiting |
NCT04061525 -
Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
|
||
Recruiting |
NCT04674449 -
iCorMicA - Stratified Medicine in Angina
|
N/A | |
Active, not recruiting |
NCT02623140 -
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
|
Phase 4 | |
Completed |
NCT03646097 -
Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study
|
N/A | |
Completed |
NCT02053818 -
Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
|
Phase 4 | |
Recruiting |
NCT04014140 -
iFR Guided Coronary Artery Bypass Grafting Surgery
|